Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
1999-12-17
2001-12-11
Kumar, Shailendra (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C548S485000, C548S486000, C546S265000, C514S332000, C514S415000, C514S616000
Reexamination Certificate
active
06329550
ABSTRACT:
BACKGROUND OF THE INVENTION
The matrix metalloproteinases (MMPs) are a family of zinc containing endopeptidases which are capable of cleaving large biomolecules such as the collagens, proteoglycans and gelatins. Expression is upregulated by pro-inflammatory cytokines and/or growth factors. The MMP's are secreted as inactive zymogens which, upon activation, are subject to control by endogenous inhibitors, for example, tissue inhibitor of metalloproteinases (TIMP) and &agr;
2
-macroglobulin. Chapman, K. T. et al.,
J. Med. Chem.
36, 4293-4301 (1993); Beckett, R. P. et al.,
DDT
1, 16-26 (1996). The characterizing feature of diseases involving the enzymes appears to be a stoichiometric imbalance between active enzymes and endogenous inhibitors, leading to excessive tissue disruption, and often degradation. McCachren, S. S.,
Arthritis Rheum.
34, 1085-1093 (1991).
The discovery of different families of matrix metalloproteinase, their relationships, and their individual characteristics have been categorized in several reports. Emonard, H. et al.,
Cell Molec. Biol.
36, 131-153 (1990); Birkedal-Hansen, H.,
J. Oral Pathol.
17, 445-451 (1988); Matrisian, L. M.,
Trends Genet.
6, 121-125 (1990); Murphy, G. J. P. et al.,
FEBS Lett.
289, 4-7 (1991); Matrisian, L. M.,
Bioessays
14, 455-463 (1992). Three groups of MMPs have been delineated: the collagenases which have triple helical interstitial collagen as a substrate, the gelatinases which are proteinases of denatured collagen and Type IV collagen, and the stromelysins which were originally characterized as proteoglycanases but have now been identified to have a broader proteolytic spectrum. Examples of specific collagenases include fibroblast collagenase characterized as proteoglycanases but have now been identified to have a broader proteolytic spectrum. Examples of specific collagenases include fibroblast collagenase (MMP-1), neutrophil collagenase (MMP-8), and collagenase 3 (MMP-13). Examples of gelatinases include 72 kDa gelatinase (gelatinase A; MMP-2) and 92 kDa gelatinase (gelatinase B; MMP-9). Examples of stromelysins include stromelysin 1 (MMP-3), stromelysin 2 (MMP-10) and matrilysin (MMP-7). Other MMPs which do not fit neatly into the above groups include metalloelastase (MMP-12), membrane-type MMP (MT-MMP or MMP-14) and stromelysin 3 (MMP-11). Beckett, R. P. et al., supra.
Over-expression and activation of MMPs have been linked with a wide range of diseases such as cancer; rheumatoid arthritis; osteoarthritis; chronic inflammatory disorders, such as emphysema and smoking-induced emphysema; cardiovascular disorders, such as atherosclerosis; corneal ulceration; dental diseases such as gingivitis and periodontal disease; and neurological disorders, such as multiple sclerosis. For example, in adenocarcinoma, invasive proximal gastric cells express the 72 kDa form of collagenase Type IV, whereas the noninvasive cells do not. Schwartz, G. K. et al.,
Cancer
73, 22-27 (1994). Rat embryo cells transformed by the Ha-ras and v-myc oncogenes or by Ha-ras alone are metastatic in nude mice and release the 92 kDa gelatinase/collagenase (MMP-9). Bernhard, E. J. et al.,
Proc. Natl. Acad. Sci.
91, 4293-4597 (1994). The plasma concentration of MMP-9 was significantly increased (P<0.01) in 122 patients with gastrointestinal tract cancer and breast cancer. Zucker, S. et al.,
Cancer Res.
53, 140-146 (1993). Moreover, intraperitoneal administration of batimastat, a synthetic MMP inhibitor, gave significant inhibition in the growth and metastatic spread and number of lung colonies which were produced by intravenous injection of the B16-BL6 murine melanoma in C57BL/6N mice. Chirivi, R. G. S. et al.,
Int. J. Cancer
58, 460-464 (1994). Over-expression of TIMP-2, the endogenous tissue inhibitor of MMP-2, markedly reduced melanoma growth in the skin of immunodeficient mice. Montgomery, A. M. P. et al.,
Cancer Res.
54, 5467-5473 (1994).
Accelerated breakdown of the extracellular matrix of articular cartilage is a key feature in the pathology of both rheumatoid arthritis and osteoarthritis. Current evidence suggests that the inappropriate synthesis of MMPs is the key event. Beeley, N. R. A. et al.,
Curr. Opin. Ther. Patents,
4(1), 7-16 (1994). The advent of reliable diagnostic tools have allowed a number of research groups to recognize that stromelysin is a key enzyme in both arthritis and joint trauma. Beeley, N. R. A. et al.,
Id.;
Hasty, K. A. et al.,
Arthr. Rheum.
33, 388-397 (1990). It has also been shown that stromelysin is important for the conversion of procollagenase to active collagenase. Murphy, G. et al.,
Biochem. J.
248, 265-268 (1987).
Furthermore, a range of MMPs can hydrolyse the membrane-bound precursor of the pro-inflammatory cytokine tumor necrosis factor &agr; (TNF-&agr;). Gearing, A. J. H. et al.,
Nature
370, 555-557 (1994). This cleavage yields mature soluble TNF-&agr; and the inhibitors of MMPs can block production of TNF-&agr; both in vitro and in vivo. Gearing, A. J. H. et al., Id.; Mohler, K. M. et al.,
Nature
370, 218-220 (1994); McGeehan, G. M. et al.,
Nature
370, 558-561 (1994). This pharmacological action is a probable contributor to the antiarthritic action of this class of compounds seen in animal models. Beckett, R. P. et al., supra.
Stromelysin has been observed to degrade the &agr;
1
-proteinase inhibitor which regulates the activity of enzymes such as elastase, excesses of which have been linked to chronic inflammatory disorders such as emphysema and chronic bronchitis. Beeley, N. R. A. et al., supra.; Wahl, R. C. et al.,
Annual Reports in Medicinal Chemistry
25, 177-184 (1990). In addition, a recent study indicates that MMP-12 is required for the development of smoking-induced emphysema in mice. Science, 277, 2002 (1997). Inhibition of the appropriate MMP may thus potentiate the inhibitory activity of endogenous inhibitors of this type.
High levels of mRNA corresponding to stromelysin have been observed in atherosclerotic plaques removed from heart transplant patients. Henney, A. M., et al.,
Proc. Natl. Acad. Sci.
88, 8154-8158 (1991). It is submitted that the role of stromelysin in such plaques is to encourage rupture of the connective tissue matrix which encloses the plaque. This rupture is in turn thought to be a key event in the cascade which leads to clot formation of the type seen in coronary thrombosis. MMP inhibition is thus a preventive measure for such thromboses.
Collagenase, stromelysin and gelatinase have been implicated in the destruction of the extracellular matrix of the cornea. This is thought to be an important mechanism of morbidity and visual loss in a number of ulcerative ocular diseases, particularly those following infection or chemical damage. Burns, F. R. et al.,
Invest. Opthalmol. and Visual Sci.
32, 1569-1575 (1989). The MMPs present in the eye during ulceration are derived either endogenously from infiltrating leucocytes or fibroblasts, or exogenously from microbes.
Collagenase and stromelysin activities have been identified in fibroblasts isolated from inflamed gingiva and the levels of enzyme have been correlated with the severity of the gingivitis observed. Beeley, N. R. A. et al., supra.; Overall, C. M. et al.,
J. Periodontal Res.
22, 81-88 (1987).
Excessive levels of gelatinase-B in cerebrospinal fluid has been linked with incidence of multiple sclerosis and other neurological disorders. Beeley, N. R. A. et al.,
supra.;
Miyazaki, K. et al.,
Nature
362, 839-841 (1993). The enzyme may play a key role in the demyelination of neurones and the breakdown of the blood brain barrier which occurs in such disorders.
SUMMARY OF THE INVENTION
The present invention provides novel aminomalonamides of the formula
wherein
R
1
and R
2
are each independently selected from the group consisting of hydrogen, C
1
-C
10
alkyl, —(CH
2
)
a
—Ar
1
, and —(CH
2
)
b
—Ar
2
; wherein
a is an integer from 1 to 6;
b is an integer from 2 to 6;
Ar
1
is a radical selected from the group consisting of
wherein R
5
is 1 or 2 substituents independently select
Janusz Michael J.
Warshawsky Alan M.
Aventis Pharmaceuticals Inc.
Gupta Balaram
Knight Julie Anne
Kumar Shailendra
Voelk Eric K.
LandOfFree
Amidomalonamides useful as inhibitors of MMP of matrix... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amidomalonamides useful as inhibitors of MMP of matrix..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amidomalonamides useful as inhibitors of MMP of matrix... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2597110